PALO ALTO, Calif.--(BUSINESS WIRE)--Medable, Inc., the leading global platform for decentralized clinical trials, and AliveCor, the leader in AI-based, personal ECG technology, today announced a ...

While Watch Series 4 and its successors will undoubtedly bring this life-saving technology to millions of people over the next several years, Apple was not the first to bring it to market. That ...

AliveCor has spent years battling with Apple over the market for consumer heart monitoring technology. Now it’s hoping to make its imprint on professional health care with its new device, which ...

Mountain View, California-based AliveCor, which makes an FDA-cleared mobile electrocardiogram (ECG) device and companion app collectively called Kardia Mobile, has released new features that make it ...

After Apple claimed its Apple Watch Series 4 would be the first FDA-cleared over-the-counter device with an electrocardiogram, AliveCor struck back, noting it obtained FDA clearance for similar ...

This morning, San Francisco-based AliveCor rebranded its AliveCor Mobile ECG device as Kardia Mobile and unveiled a second, upcoming hardware product, an Apple Watch strap that can take ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Gadgets are fun to use, but they rarely get FDA clearance to be marketed ...

Health technology company AliveCor, maker of connected electrocardiogram devices, is trying to ban U.S. sales of the Apple Watch, claiming the tech giant allegedly infringed on three of its patents.

AliveCor has ceased sales of the KardiaBand, an ECG smart band for the Apple Watch that added the heart-monitoring functionality to the wearable device, but while there is no explanation for the ...

During the unveiling of the latest Apple watch in San Francisco this week, the company’s Chief Operating Officer Jeff Williams made a claim that’s been described as "alternative facts" by another ...